A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome.
about
Metformin in polycystic ovary syndrome: systematic review and meta-analysisClomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysisInsulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertilityInsulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertilityInsulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndromeDecreased androgen levels and improved menstrual pattern after angiotensin II receptor antagonist telmisartan treatment in four hypertensive patients with polycystic ovary syndrome: case seriesMetformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysisA retrospective survey of quality of reporting on randomized controlled trials of metformin for polycystic ovary syndromePregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview.Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis.Metformin and polycystic ovary syndrome.Antioxidants and management of polycystic ovary syndrome in Iran: A systematic review of clinical trials.Aromatase inhibitors for the treatment of infertility.Association between Hypoadiponectinemia and Low Serum Concentrations of Calcium and Vitamin D in Women with Polycystic Ovary SyndromeMultiple gestation and infertility treatment: registration, reflection and reaction--the Belgian project.Managing anovulatory infertility and polycystic ovary syndromeDoes metformin improve in vitro maturation and ultrastructure of oocytes retrieved from estradiol valerate polycystic ovary syndrome-induced rats.Clomiphene citrate, metformin or a combination of both as the first line ovulation induction drug for Asian Indian women with polycystic ovarian syndrome: A randomized controlled trialMetformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review.Impact of obesity on female reproductive health: British Fertility Society, Policy and Practice Guidelines.Effects of insulin-sensitizing agents and insulin resistance in women with polycystic ovary syndromeThe efficacy of metformin and clomiphene citrate combination compared with clomiphene citrate alone for ovulation induction in infertile patients with PCOSPhenotypic and pharmacogenetic aspects of ovulation induction in WHO II anovulatory women.Use of metformin in the treatment of polycystic ovary syndrome.Insulin resistance and the long-term consequences of polycystic ovary syndrome.Is metformin indicated as primary ovulation induction agent in women with PCOS? A systematic review and meta-analysis.Evidence-based lifestyle and pharmacological management of infertility in women with polycystic ovary syndrome.Treatment strategies for the infertile polycystic ovary syndrome patient.Effect of metformin on clinical, metabolic and endocrine outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials.Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: Aggravated complication of pregnancy.Modulation of the IGF system and proliferation in human endometrial stromal cells by metformin: a dose-dependent effect.The effect of metformin use on pregnancy rates among polycystic ovary syndrome patients undergoing in vitro fertilization: A retrospective-cohort study.Clinical outcomes of ovulation induction with metformin, clomiphene citrate and human menopausal gonadotrophin in polycystic ovary syndrome.Evaluation of process efficiency and bioequivalence of biosimilar recombinant human chorionic gonadotropin (rhCG).Efficacy of metformin on ovulation induction in Asian women with polycystic ovary syndrome.Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management.Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.Effects of metformin on the expression of GLUT4 in endometrium of obese women with polycystic ovary syndrome.
P2860
Q22242098-616B9128-FA6F-438E-819A-A03A624244ABQ22242629-B3FEB742-C472-4AE5-8F47-A37861B1B3B0Q24197673-8D091FC6-6EDA-4CF7-9CCD-C6A7D8C3DB7CQ24240654-363494E9-FA11-44B2-BD74-8D75139578B0Q24246323-D97EF18F-47C4-4744-87A0-E2A3A34658A1Q24645442-9B18DE4A-A24A-4685-B48C-6EA483A23F3DQ28088433-42CDBAF6-F6DD-4273-8D38-50C6242405D0Q33614259-21C80781-71A4-4A5F-B366-2B7ACD18C8B9Q34257603-CECBB0AC-650A-4E31-9764-A27DA1FE779DQ34298086-3AF079FA-89D2-425A-B7AA-5667D1C48559Q34746925-72C7FE96-D2AA-44CB-9E31-DFD1B7C0DA4FQ35015466-2795256E-C955-4C14-9862-07A56057BA54Q35073337-31C08B8F-A0EC-4F9E-8674-5EECEC298266Q35692065-43AB7215-AE46-47D0-8786-86521242A0EDQ35940387-0E69ECA4-F706-4B1E-8881-1EDB19E74995Q36016556-9DB08E9F-5CDE-4A9F-86CB-31997F9741CCQ36292791-5C991031-4602-4280-AFE4-56E41D49A57AQ36406468-FDEE1FAA-D9A7-4A97-AE9D-7ADC0DEF717FQ36721550-F35D6AF4-7B34-42CA-B842-23A692068389Q37020199-DA5116BB-9E16-4E37-BFF2-FAA4442F30A5Q37022386-8C81027D-1074-4A7F-BC99-00825B7CA58DQ37238230-B9E18F44-AAD3-4048-8CD6-DCBD6B9F1778Q37466378-DB868CBB-162A-4C47-8984-105BE37FF348Q37769526-A22EB2CF-24D2-4E17-BF5F-975C49AA4DEFQ37833622-D90A1A20-5775-4D8A-A686-6E711ABE5D3EQ38003834-82DD1C07-B943-48B8-8867-8C5437EF468FQ38007200-24AA2E9F-F35B-4CB2-887A-E2CC32ED311DQ38655294-64A10372-17B0-4013-8FFB-6C1D9C14071DQ39036760-08FC0639-0717-4909-A336-8F40407F51E5Q41116375-2F47B766-8C68-41F1-A392-FB860FCEEC7EQ41425232-570781BE-F9FF-4D03-AFB0-8A55A2DF93C0Q41690430-C324FB80-D531-4238-964D-3BE3610CF4F4Q42868397-922D7AE7-3540-4DE0-A1CD-C755668771CAQ44298591-65BD97A6-6D36-4ECB-ABBC-51090E6A5BE9Q45277767-725310CA-EBD3-4927-9208-7DC6C3D876ACQ45282214-096AABAB-A871-4A47-922F-35FB06955E41Q46731864-26461B85-F275-4E7B-AF31-6BEE447F0EFDQ47402228-ACE89606-F603-4832-A4A8-1112B4F7702BQ51357044-F06D924C-4664-4189-ABD4-84E41095AC9C
P2860
A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
A systematic review of the rep ...... ith polycystic ovary syndrome.
@en
type
label
A systematic review of the rep ...... ith polycystic ovary syndrome.
@en
prefLabel
A systematic review of the rep ...... ith polycystic ovary syndrome.
@en
P1476
A systematic review of the rep ...... ith polycystic ovary syndrome.
@en
P2093
John A Eden
Michael F Costello
P356
10.1016/S0015-0282(02)04554-5
P407
P577
2003-01-01T00:00:00Z